Ok Biotech Co., Ltd.(TW:4155)
NT$16.90-0.60 (-3.43%)
TW:4155
Ok Biotech Co., Ltd. financials statements
NT$16.90
At close:-0.60 (-3.43%)
Ok Biotech Co., Ltd. (4155) Financial Statements
Ok Biotech Co., Ltd. Financial Overview
Ok Biotech Co., Ltd.'s market cap is currently NT$2.19B. The company's EPS TTM is NT$1.71; its P/E ratio is 10.00; and it has a dividend yield of 1.78%. Ok Biotech Co., Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | NT$ 1.56B | NT$ 1.67B | NT$ 1.19B | NT$ 1.48B | NT$ 1.26B |
| Gross Profit | NT$ 429.25M | NT$ 275.65M | NT$ 196.88M | NT$ 344.96M | NT$ 186.83M |
| Operating Income | NT$ 107.89M | NT$ 57.21M | NT$ -12.06M | NT$ 211.62M | NT$ 49.31M |
| EBITDA | NT$ 201.51M | NT$ 205.76M | NT$ 87.24M | NT$ 247.47M | NT$ 85.45M |
| Net Income | NT$ 82.45M | NT$ 93.97M | NT$ 2.95M | NT$ 143.46M | NT$ 31.42M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | NT$ 327.06M | NT$ 290.50M | NT$ 365.34M | NT$ 636.64M | NT$ 644.63M |
| Total Assets | NT$ 3.85B | NT$ 3.70B | NT$ 3.07B | NT$ 3.06B | NT$ 2.81B |
| Total Debt | NT$ 1.03B | NT$ 779.43M | NT$ 332.98M | NT$ 780.64M | NT$ 735.74M |
| Net Debt | NT$ 719.51M | NT$ 501.97M | NT$ 9.94M | NT$ 184.22M | NT$ 135.88M |
| Total Liabilities | NT$ 1.27B | NT$ 1.13B | NT$ 672.26M | NT$ 1.21B | NT$ 1.11B |
| Stockholders' Equity | NT$ 2.51B | NT$ 2.49B | NT$ 2.40B | NT$ 1.84B | NT$ 1.70B |
| Cash Flow | |||||
| Free Cash Flow | NT$ -89.57M | NT$ -308.81M | NT$ -434.15M | NT$ -53.72M | NT$ -64.57M |
| Operating Cash Flow | NT$ 319.57M | NT$ 65.90M | NT$ 2.93M | NT$ 240.53M | NT$ 21.90M |
| Investing Cash Flow | NT$ -398.50M | NT$ -444.93M | NT$ -358.38M | NT$ -294.23M | NT$ -174.46M |
| Financing Cash Flow | NT$ 113.04M | NT$ 338.02M | NT$ 82.06M | NT$ 50.27M | NT$ 185.69M |
Currency in TWD
